Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissue

A composition and medicine technology, applied in the field of diversion invention, can solve the problems of dehydration, shedding, atrophy and the like of diseased tissue, and achieve the effects of low price, convenient use and remarkable curative effect

Active Publication Date: 2016-06-01
谭国梁 +2
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although the above-mentioned substances are known as flocculants, so far, in the medical field, no one has used these properties to dehydrate, shrink, and even shed diseased tissues in living bodies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissue
  • A pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissue
  • A pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissue

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: Get 10 grams of polyferric sulfate and 90 grams of distilled water to dissolve, pack in aseptic ampoules, 3ml / ampoules, vacuumize, and melt seal. When applied, dilute it with 1.5% levobupivacaine and 1.0% methylene blue injection to become 5% polyferric sulfate 0.75% levobupivacaine 0.5% methylene blue injection, and treat various diseases with appropriate dosage. Types of hemorrhoids, hemangiomas, varicose veins, hemorrhagic hematomas.

[0033] Operation procedure: clean and disinfect the affected area; draw an appropriate amount of injection, inject fractional points into hemorrhoids, hemangiomas, hematomas, and thrombus, and gently rub with cotton sticks to distribute evenly. Hemorrhoids, hemangiomas, and thrombus will harden in a few seconds; 1. The hemangioma becomes soft, dehydrated, shriveled, and disappears; the dehydration and atrophy process is completed within ten to twenty minutes; seven to fourteen days, the diseased tissue is replaced by norm...

Embodiment 2

[0034] Embodiment 2: Dissolve 7 grams of polyferric silicate sulfate (PFSS) and 93 grams of distilled water, pack in aseptic ampoules, 3ml / ampule, vacuumize, and melt seal. When applying, dilute it with 1.5% levobupivacaine 1.0% methylene blue injection to become 3.5% polysilicic acid ferric sulfate 0.75% levobupivacaine 0.5% methylene blue injection. Types of hemorrhoids, hemangiomas, varicose veins, hemorrhagic hematomas.

Embodiment 3

[0035] Example 3: Dissolve 7 grams of polyferric silicate (PFSC) and 93 grams of distilled water, pack in sterile ampoules, 3ml / ampule, vacuumize, and melt seal. When applied, dilute it with 1.5% levobupivacaine 1.0% methylene blue injection to become 3.5% polysilicon ferric chloride 0.75% levobupivacaine 0.5% methylene blue injection, with an appropriate dose, Treatment of various types of hemorrhoids, hemangioma, varicose veins, hemorrhagic hematoma.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition capable of dehydrating, shrinking and eliminating diseased tissues, wherein the pharmaceutical composition has inorganic high molecular weight iron salt and / or inorganic high molecular weight iron salt complex as its active ingredient; The molecular iron salt can be polyferric sulfate (PFS), and the inorganic polymer iron salt complex can be selected from polymeric silicic acid complex iron salts, polymeric phosphate complex iron salts and / or their analogues. The diseased tissue is treated with the pharmaceutical composition of the invention to make it dehydrated, shrunk, absorbed or shed, thereby inhibiting the diseased tissue and achieving unexpected effects. The pharmaceutical composition of the present invention is low in price, remarkable in curative effect, convenient to use, and can effectively treat hemorrhoids, hemangiomas, varicose vessels, cysts, abscesses, tumors, water and fire burns, traumatic bleeding, local damage of microorganisms and chemical poisons, and the like.

Description

technical field [0001] The invention relates to a pharmaceutical composition for dehydrating, shrinking and eliminating diseased tissues in the field of medical innovation, and belongs to a diversion invention. Background technique [0002] Polymeric ferric sulfate (PFS) is basic ferric sulfate [ferricsubsulfate, molecular formula: Fe 4 (OH) 2 (SO4) 5 ] Polymer, referred to as Polyferric Sulfate (Polyferric Sulfate), the general chemical formula is [Fe 2 (OH) n (SO4) 3-0.5n ] m, wherein, 0.5<n<1, m=f(n). [0003] Traditionally, polyferric sulfate is an inorganic polymer iron salt flocculant. Compared with other various flocculants, it has the advantages of less dosage in the purification process, wide applicable pH range, high removal rate of impurities (turbidity, COD, suspended solids, etc.), low residue concentration, fast settling speed of alum flowers, and decolorization It is widely used in the purification treatment of industrial wastewater, urban sewage,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K33/26A61K33/42A61K45/00A61P7/04A61P9/00A61P9/14A61P17/02A61P35/00
CPCA61K33/26A61P7/04A61P9/00A61P9/14A61P17/02A61P35/00A61P43/00A61K2300/00
Inventor 谭国梁谭晓雯谭晓晴
Owner 谭国梁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com